GLYSTORZYN Trademark

Trademark Overview

On Wednesday, May 13, 2015, a trademark application was filed for GLYSTORZYN with the United States Patent and Trademark Office. The USPTO has given the GLYSTORZYN trademark a serial number of 86627882. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, December 30, 2022. This trademark is owned by Sanofi. The GLYSTORZYN trademark is filed in the Pharmaceutical Products category with the following description:

Anti-diabetic preparations
glystorzyn

General Information

Serial Number86627882
Word MarkGLYSTORZYN
Filing DateWednesday, May 13, 2015
Status710 - CANCELLED - SECTION 8
Status DateFriday, December 30, 2022
Registration Number4976375
Registration DateTuesday, June 14, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 29, 2016

Trademark Statements

Goods and ServicesAnti-diabetic preparations

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, December 30, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSanofi
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
Address75008 Paris
FR
Party NameSanofi
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
Address75008 Paris
FR
Party NameSanofi
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
Address75008 Paris
FR

Trademark Events

Event DateEvent Description
Friday, December 30, 2022CANCELLED SEC. 8 (6-YR)
Monday, June 14, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, January 8, 2020REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
Tuesday, December 10, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 5, 2017REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
Tuesday, January 31, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 14, 2016REGISTERED-PRINCIPAL REGISTER
Tuesday, March 29, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 29, 2016PUBLISHED FOR OPPOSITION
Wednesday, March 9, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 23, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, February 17, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 17, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 17, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 11, 2016ASSIGNED TO LIE
Friday, February 5, 2016TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Friday, February 5, 2016NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Friday, February 5, 2016INQUIRY TO SUSPENSION E-MAILED
Friday, February 5, 2016SUSPENSION INQUIRY WRITTEN
Wednesday, August 5, 2015NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, August 5, 2015LETTER OF SUSPENSION E-MAILED
Wednesday, August 5, 2015SUSPENSION LETTER WRITTEN
Wednesday, August 5, 2015ASSIGNED TO EXAMINER
Wednesday, May 20, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, May 16, 2015NEW APPLICATION ENTERED

Related Keywords

glystorzyn preparations diabetic anti